A game changing service-led innovation in menopause management
A game changing service-led innovation in menopause management
批准号:
10032341
负责人:
金额:
$25.44万
依托单位:
依托单位国家:
英国
项目类别:
Investment Accelerator
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
更年期是一种长期的荷尔蒙缺乏,每个女人都会经历。目前的管理策略侧重于疾病而不是健康,临床医生受到缺乏客观和准确的检测选择的限制。这使得女性的选择和治疗计划有限,没有受到有效性监测。敏捷生命科学(ALS)开发了一项改变游戏规则的服务,可以测量和监测激素变化对阴道微生物群-阴道微生物群的影响。这项高度创新的服务将为更年期临床医生提供强大的数据,帮助指导他们为围绝经期和绝经后妇女提供尽可能最佳的护理和治疗计划。我们的项目专注于开发一种解决方案,使用最先进的下一代测序技术来分析尿样,以测量和监测阴道内的细菌。通过监测这些细菌的变化,我们可以识别更年期和尿路感染的风险。通过与更年期临床医生、关键意见领袖和最终用户合作,我们将开发一种为围绝经期和绝经后妇女量身定做的服务,使她们能够控制自己的健康,过上不受限制的生活。我们的居家轻松样本采集设计为方便,允许女性在尖端技术的支持下管理她们的更年期旅程。该项目的结果将是对更年期临床医生的全面服务测试,在4个月内试点推出协作式KOL,并在9个月内推出全面服务。
英文摘要
Menopause is a long-term hormone deficiency which will be experienced by every woman. The current management strategies focus on illness not wellness and clinicians are limited by lack of objective and accurate testing options. This leaves women with limited options and treatment plans that are not monitored for efficacy.Agile Life Sciences (ALS) has developed a game changing service which can measure and monitor the effects of hormone changes on the vaginal microbiome - the vaginome.This highly innovative service will provide menopause clinicians with robust data to help guide them in providing the best possible care and treatment plans to peri and post menopausal women.Our project focusses on developing a solution which uses state-of-the-art next generation sequencing technology to analyse urine samples to measure and monitor the bacteria in the vaginome. By monitoring the changes in these bacteria we can identify the menopause phase and the risk of UTIs.By partnering with menopause clinicians, key opinion leaders and end users we will develop a service that is tailored to peri and post menopausal women and enables them to take control of their own health and live a life without limitations. Our at home easy sample collection has been designed to be convenient and allows women to manage their menopause journey with the support of cutting-edge technology.The outcome of the project will be a fully serviceable test for menopause clinicians with a pilot launch to collaborative KOLs within 4 months and the full service launch within 9 months.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Exploring Changing Fertility Intentions in China
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:MINHEE CHAE
-
依托单位: